214 related articles for article (PubMed ID: 33285229)
1. Prospective therapeutic potential of Tanshinone IIA: An updated overview.
Ansari MA; Khan FB; Safdari HA; Almatroudi A; Alzohairy MA; Safdari M; Amirizadeh M; Rehman S; Equbal MJ; Hoque M
Pharmacol Res; 2021 Feb; 164():105364. PubMed ID: 33285229
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases.
Guo R; Li L; Su J; Li S; Duncan SE; Liu Z; Fan G
Drug Des Devel Ther; 2020; 14():4735-4748. PubMed ID: 33192051
[No Abstract] [Full Text] [Related]
3. A comprehensive review of tanshinone IIA and its derivatives in fibrosis treatment.
Bi Z; Wang Y; Zhang W
Biomed Pharmacother; 2021 May; 137():111404. PubMed ID: 33761617
[TBL] [Abstract][Full Text] [Related]
4. Tanshinone IIA: A Review of its Anticancer Effects.
Fang ZY; Zhang M; Liu JN; Zhao X; Zhang YQ; Fang L
Front Pharmacol; 2020; 11():611087. PubMed ID: 33597880
[TBL] [Abstract][Full Text] [Related]
5. Tanshinone IIA alleviates cardiac hypertrophy through m6A modification of galectin-3.
Zhang M; Chen Y; Chen H; Shen Y; Pang L; Wu W; Yu Z
Bioengineered; 2022 Feb; 13(2):4260-4270. PubMed ID: 35191812
[TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro.
Ding B; Lin C; Liu Q; He Y; Ruganzu JB; Jin H; Peng X; Ji S; Ma Y; Yang W
J Neuroinflammation; 2020 Oct; 17(1):302. PubMed ID: 33054814
[TBL] [Abstract][Full Text] [Related]
7. Tanshinone-IIA mediated neuroprotection by modulating neuronal pathways.
Sherawat K; Mehan S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Aug; 396(8):1647-1667. PubMed ID: 37010572
[TBL] [Abstract][Full Text] [Related]
8. Upregulation effects of Tanshinone IIA on the expressions of NeuN, Nissl body, and IκB and downregulation effects on the expressions of GFAP and NF-κB in the brain tissues of rat models of Alzheimer's disease.
Li J; Wen PY; Li WW; Zhou J
Neuroreport; 2015 Sep; 26(13):758-66. PubMed ID: 26164608
[TBL] [Abstract][Full Text] [Related]
9. Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats.
Wang D; Yu W; Cao L; Xu C; Tan G; Zhao Z; Huang M; Jin J
Biopharm Drug Dispos; 2020 Feb; 41(1-2):54-63. PubMed ID: 31943245
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA attenuates cerebral aneurysm formation by inhibiting the NF‑κB‑mediated inflammatory response.
Ma J; Hou D; Wei Z; Zhu J; Lu H; Li Z; Wang X; Li Y; Qiao G; Liu N
Mol Med Rep; 2019 Aug; 20(2):1621-1628. PubMed ID: 31257487
[TBL] [Abstract][Full Text] [Related]
11. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation.
Guan Z; Chen J; Li X; Dong N
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776119
[TBL] [Abstract][Full Text] [Related]
12. Direct vasorelaxation by a novel phytoestrogen tanshinone IIA is mediated by nongenomic action of estrogen receptor through endothelial nitric oxide synthase activation and calcium mobilization.
Fan G; Zhu Y; Guo H; Wang X; Wang H; Gao X
J Cardiovasc Pharmacol; 2011 Mar; 57(3):340-7. PubMed ID: 21383591
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective Effects of Tanshinone IIA: A Literature Review.
Chen Z; Feng H; Peng C; Zhang Z; Yuan Q; Gao H; Tang S; Xie C
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838978
[TBL] [Abstract][Full Text] [Related]
14. Tanshinone IIA exerts therapeutic effects by acting on endogenous stem cells in rats with liver cirrhosis.
Yang N; Chen H; Gao Y; Zhang S; Lin Q; Ji X; Li N; Xu W; Liu Y; Jin S
Biomed Pharmacother; 2020 Dec; 132():110815. PubMed ID: 33113421
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of tanshinone IIA on rat hepatic stellate cells.
Liu YW; Huang YT
PLoS One; 2014; 9(7):e103229. PubMed ID: 25076488
[TBL] [Abstract][Full Text] [Related]
16. Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine.
Zhang W; Liu C; Li J; Lu Y; Li H; Zhuang J; Ren X; Wang M; Sun C
Am J Chin Med; 2022; 50(1):209-239. PubMed ID: 34983327
[TBL] [Abstract][Full Text] [Related]
17. The anti-inflammatory activities of Tanshinone IIA, an active component of TCM, are mediated by estrogen receptor activation and inhibition of iNOS.
Fan GW; Gao XM; Wang H; Zhu Y; Zhang J; Hu LM; Su YF; Kang LY; Zhang BL
J Steroid Biochem Mol Biol; 2009 Feb; 113(3-5):275-80. PubMed ID: 19429433
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of tanshinone IIa on endothelial cells: a generalist among clinical therapeutics.
Feng J; Liu L; Yao F; Zhou D; He Y; Wang J
Expert Rev Clin Pharmacol; 2021 Feb; 14(2):239-248. PubMed ID: 33463381
[TBL] [Abstract][Full Text] [Related]
19. Recent Research Progress (2015-2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA.
Zhong C; Lin Z; Ke L; Shi P; Li S; Huang L; Lin X; Yao H
Front Pharmacol; 2021; 12():778847. PubMed ID: 34819867
[TBL] [Abstract][Full Text] [Related]
20. Sodium tanshinone IIA sulfonate: A review of pharmacological activity and pharmacokinetics.
Zhou ZY; Zhao WR; Zhang J; Chen XL; Tang JY
Biomed Pharmacother; 2019 Oct; 118():109362. PubMed ID: 31545252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
